English
Klinische FragestellungGestörte mitochondriale DNA-Instandhaltung, Differentialdiagnose
Zusammenfassung
Kurzinformation
Umfassendes differentialdiagnostisches panel für Gestörte mitochondriale DNA-Instandhaltung / mtDNA maintenance disorders mit 25 Leitlinien-kuratierten sowie insgesamt 27 kuratierten Genen
ID
MP3354
Anzahl Gene
26
Akkreditierte Untersuchung
Untersuchte Sequenzlänge
37,2 kb (Core-/Core-canditate-Gene)
42,8 kb (Erweitertes Panel: inkl. additional genes)
42,8 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
- EDTA-Blut (3-5 ml)
Diagnostische Hinweise
NGS +
Genpanel
Ausgewählte Gene
| Name | Exon-Länge (bp) | OMIM-G | Referenz-Seq. | Erbgang |
|---|---|---|---|---|
| ABAT | 1503 | NM_000663.5 | AR | |
| AFG3L2 | 2394 | NM_006796.3 | AD, AR | |
| AGK | 1269 | NM_018238.4 | AR | |
| DGUOK | 834 | NM_080916.3 | AR | |
| DNA2 | 3183 | NM_001080449.3 | AD | |
| FBXL4 | 1866 | NM_012160.5 | AR | |
| GFER | 618 | NM_005262.3 | AR | |
| MFN2 | 2274 | NM_014874.4 | AR | |
| MGME1 | 1035 | NM_052865.4 | AR | |
| MPV17 | 531 | NM_002437.5 | AR | |
| OPA1 | 2883 | NM_015560.3 | AD, AR | |
| POLG | 3720 | NM_002693.3 | AR, AD | |
| POLG2 | 1458 | NM_007215.4 | AD, AR | |
| RNASEH1 | 869 | NM_002936.6 | AR | |
| RRM2B | 1272 | NM_015713.5 | AR | |
| SLC25A21 | 897 | NM_001171170.2 | AR | |
| SLC25A4 | 897 | NM_001151.4 | AD, AR | |
| SPG7 | 2388 | NM_003119.4 | AR, AD | |
| SUCLA2 | 1392 | NM_003850.3 | AR | |
| SUCLG1 | 1041 | NM_003849.4 | AR | |
| TFAM | 645 | NM_001270782.2 | AR | |
| TK2 | 705 | NM_001172643.1 | AR | |
| TWNK | 2055 | NM_021830.5 | AD, AR | |
| TYMP | 1449 | NM_001953.5 | AR | |
| DNM2 | 2613 | NM_001005360.3 | AD | |
| TOP3A | 3006 | NM_004618.5 | AR |
Infos zur Erkrankung
Synonyme
- Allelic: Optic atrophy 5 (DNM1L)
- Behr syndrome (OPA1)
- Cataract 38, AR (AGK)
- Centronuclear myopathy 1 (DNM2)
- Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
- Charcot-Marie-Tooth disease, axonal, type 2A2A (MFN2)
- Charcot-Marie-Tooth disease, axonal, type 2A2B (MFN2)
- Charcot-Marie-Tooth disease, axonal, type 2EE (MPV17)
- Charcot-Marie-Tooth disease, dominant intermediate B (DNM2)
- Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 (DNM1L)
- GABA-transaminase deficiency (ABAT)
- Glaucoma, normal tension, susceptibility to (OPA1)
- Hereditary motor + sensory neuropathy VIA (MFN2)
- Lethal congenital contracture syndrome 5 (DNM2)
- Microcephaly, growth restriction + increased sister chromatid exchange 2 (TOP3A)
- Mitochondrial DNA depletion syndrome 1 [MNGIE type] (TYMP)
- Mitochondrial DNA depletion syndrome 11 (MGME1)
- Mitochondrial DNA depletion syndrome 12A [cardiomyopathic type] (SLC25A4)
- Mitochondrial DNA depletion syndrome 12B [cardiomyopathic type] (SLC25A4)
- Mitochondrial DNA depletion syndrome 13 [encephalomyopathic type] (FBXL4)
- Mitochondrial DNA depletion syndrome 14 [encephalocardiomyopathic type] (OPA1)
- Mitochondrial DNA depletion syndrome 15 [hepatocerebral type] (TFAM)
- Mitochondrial DNA depletion syndrome 16 [hepatic type] (POLG2)
- Mitochondrial DNA depletion syndrome 18 (SLC25A21)
- Mitochondrial DNA depletion syndrome 2 [myopathic type] (TK2)
- Mitochondrial DNA depletion syndrome 3 [hepatocerebral type] (DGUOK)
- Mitochondrial DNA depletion syndrome 4A [Alpers type] (POLG)
- Mitochondrial DNA depletion syndrome 4B [MNGIE type] (POLG)
- Mitochondrial DNA depletion syndrome 5 [encephalomyopathic +/- methylmalonic aciduria] (SUCLA)
- Mitochondrial DNA depletion syndrome 6 [hepatocerebral type] (MPV17)
- Mitochondrial DNA depletion syndrome 7 [hepatocerebral type] (TWNK)
- Mitochondrial DNA depletion syndrome 8A [encephalomyopathic with renal tubulopathy] (RRM2B)
- Mitochondrial DNA depletion syndrome 8B [MNGIE type] (RRM2B)
- Mitochondrial DNA depletion syndrome 9 [encephalomyopathic type + methylmalonic aciduria] (SUCLG1)
- Mitochondrial recessive ataxia syndrome [includes SANDO + SCAE] (POLG)
- Myopathy, mitochondrial progressive, congenital cataract + developmental delay (GFER)
- Optic atrophy 1 (OPA1)
- Optic atrophy 12 (AFG3L2)
- Optic atrophy plus syndrome (OPA1)
- Perrault syndrome 5 (TWNK)
- Portal hypertension, noncirrhotic (DGUOK)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 2 (SLC25A4)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 3 (TWNK)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 4 (POLG2)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 5 (RRM2B)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AD 6 (DNA2)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 2 (RNASEH1)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 3 (TK2)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 4 (DGUOK)
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, AR 5 (TOP3A)
- Progressive external ophthalmoplegia, AD 1 (POLG)
- Progressive external ophthalmoplegia, AR 1 (POLG)
- Seckel syndrome 8 (DNA2)
- Sengers syndrome (AGK)
- Spastic ataxia 5, AR (AFG3L2)
- Spastic paraplegia 7, AR (SPG7)
- Spinocerebellar ataxia 28 (AFG3L2)
Erbgänge, Vererbungsmuster etc.
- AD
- AR
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatik und klinische Interpretation
Kein Text hinterlegt